Form D · Other
Dorian Broadway Limited Partnership
New York, NY · CIK 0002035619
Offering snapshot reported Apr 21, 2025 · SEC filing
- Reported sold
- $8.3M Offering amount: $8.75M
- Investors reported
- 53 Form D · investor count
- Minimum accepted
- $25K Reported outside-investor minimum
- First sale
- Nov 11, 2024 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
- Reported investors0 → 53
- Minimum accepted$50,000 → $25,000
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Apr 21, 2025 | Amendment | $8,297,262 | No comparison | 53 | SEC filing |
| Oct 4, 2024 | Initial | Yet to sell | No comparison | 0 | SEC filing |
Offering details
- Securities
- Other
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-525949
Maximum capitalization was $8,750,000/Minimum capitalization was $7,750,000/Offering capitalized at $8,297,262
Limited partnership interests in Dorian Broadway Limited Partnership, a theatrical production company.
Source: Form D, filed Apr 21, 2025. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Michael Cassel | Director, Executive |
| Adam Kenwright | Director, Executive |
| Amanda Lipitz | Director, Executive |
| Daryl Roth | Director, Executive |
| Henry Tisch | Director, Executive |
Issuer details
Industry: Other (See others in industry)
Address:
C/O Foresight Theatrical 1650 Broadway, Suite 800
New York, NY, 10019
New York, NY, 10019